Shandong Realcan Pharmaceutical Co Ltd
Realcan Pharmaceutical Group Co., Ltd. sells medicines, medical devices, and medical consumables to medical institutions in China. It operates through the Drug and Equipment Distribution, In Vitro Diagnostics, Pharmaceutical Logistics, Traditional Chinese Medicine, and Microbiome Medicine segments. The company engages in the processing, manufacture, sale, and wholesale of Chinese medicinal materi… Read more
Shandong Realcan Pharmaceutical Co Ltd - Asset Resilience Ratio
Shandong Realcan Pharmaceutical Co Ltd (002589) has an Asset Resilience Ratio of -4.18% as of March 2024. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2015–2023)
This chart shows how Shandong Realcan Pharmaceutical Co Ltd's Asset Resilience Ratio has changed over time. Compare with other companies' asset resilience ratios.
Liquid Assets Composition Over Time
This chart breaks down Shandong Realcan Pharmaceutical Co Ltd's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | CN¥0.00 | 0% |
| Short-term Investments | CN¥-650.47 Million | -4.18% |
| Total Liquid Assets | CN¥-650.47 Million | -4.18% |
Asset Resilience Insights
- Limited Liquidity: Shandong Realcan Pharmaceutical Co Ltd maintains only -4.18% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company primarily holds liquidity in cash and equivalents rather than short-term investments.
Shandong Realcan Pharmaceutical Co Ltd Industry Peers by Asset Resilience Ratio
Compare Shandong Realcan Pharmaceutical Co Ltd's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
C.Q. Pharmaceutical Holding Co Ltd
SHE:000950 |
Medical Distribution | 0.00% |
|
Shenzhen Glory Medical Co Ltd
SHE:002551 |
Medical Distribution | 10.46% |
|
Hanmi Science
KO:008930 |
Medical Distribution | 0.06% |
|
BCM Alliance Bhd
KLSE:0187 |
Medical Distribution | 17.12% |
|
Qingdao Baheal Medical INC.
SHE:301015 |
Medical Distribution | 3.50% |
|
Excelsior Medical Co Ltd
TW:4104 |
Medical Distribution | 3.70% |
|
CHC Healthcare Group
TW:4164 |
Medical Distribution | 0.46% |
|
China Meheco Co Ltd
SHG:600056 |
Medical Distribution | 0.35% |
Annual Asset Resilience Ratio for Shandong Realcan Pharmaceutical Co Ltd (2015–2023)
The table below shows the annual Asset Resilience Ratio data for Shandong Realcan Pharmaceutical Co Ltd.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2023-12-31 | -3.99% | CN¥-666.13 Million | CN¥16.71 Billion | +1.98pp |
| 2022-12-31 | -5.97% | CN¥-1.09 Billion | CN¥18.33 Billion | -3.05pp |
| 2021-12-31 | -2.92% | CN¥-770.06 Million | CN¥26.40 Billion | -3.05pp |
| 2020-12-31 | 0.13% | CN¥40.79 Million | CN¥31.29 Billion | -0.48pp |
| 2019-12-31 | 0.61% | CN¥198.09 Million | CN¥32.47 Billion | +0.39pp |
| 2018-12-31 | 0.22% | CN¥77.83 Million | CN¥34.84 Billion | +0.21pp |
| 2017-12-31 | 0.01% | CN¥2.54 Million | CN¥26.98 Billion | +0.08pp |
| 2016-12-31 | -0.07% | CN¥-11.55 Million | CN¥15.66 Billion | +0.00pp |
| 2015-12-31 | -0.08% | CN¥-6.91 Million | CN¥8.86 Billion | -- |